Results 101 to 110 of about 19,945,001 (395)

Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England

, 2015
Background: chronic kidney disease (CKD) diagnosis relies on glomerular filtration rate (eGFR) estimation, traditionally using the creatinine-based Modification of Diet in Renal Disease (MDRD) equation.
Aitken, Grant, Day, Julie, Fraser, Simon D.S., Mindell, Jennifer S., Moon, Graham, O’Donoghue, Donal, Roderick, Paul J., Taal, Maarten W.   +7 more
core   +1 more source

OXidative Stress PREDictor: A Supervised Learning Approach for Annotating Cellular Oxidative Stress States in Inflammatory Cells

Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.
OxSpred, an eXtreme‐Gradient‐Boosting‐‐based supervised learning model, accurately annotates oxidative stress in innate immune cells at the single‐cell level, providing interpretable embeddings with significant biological relevance. This innovative tool revolutionizes the understanding of innate immune cell functions during inflammation and enhances ...
Po‐Yuan Chen, Tai‐Ming Ko
wiley   +1 more source

Increased Cystatin C in Astrocytes of Transgenic Mice Expressing the K670N-M671L Mutation of the Amyloid Precursor Protein and Deposition in Brain Amyloid Plaques

Neurobiology of Disease, 2001
Cystatin C is an essential secretory cofactor for neurogenesis with potent protease inhibitor activities. Polymorphisms of cystatin C are genetically associated with Alzheimer's disease (AD), and the L68Q mutation causes hereditary cerebral hemorrhage ...
Tiana Steinhoff, Eva Moritz, M.Axel Wollmer, M.Hasan Mohajeri, Stefan Kins, Roger M. Nitsch   +5 more
doaj  

Cystatin C and Subclinical Brain Infarction [PDF]

Journal of the American Society of Nephrology, 2005
Subclinical brain infarcts (SBI) are common in the elderly and are associated with covert neurologic and cognitive impairment. Although renal impairment is associated with accelerated cerebrovascular disease and an increased risk for clinically apparent brain infarct, few studies have examined the relationship between renal function and SBI, and these ...
David S. Siscovick, Stephen L. Seliger, Anthony J. Bleyer, Catherine Stehman-Breen, Linda F. Fried, Ronit Katz, Michael G. Shlipak, Anne B. Newman, Mark J. Sarnak, Teri A. Manolio, Daniel L. Gillen, W. T. Longstreth   +11 more
openaire   +3 more sources

Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis

American Journal of Hematology, EarlyView.
ABSTRACT Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging system and renal response criteria are based on proteinuria and creatinine‐based eGFR.
Foteini Theodorakakou, Despina Fotiou, Filia Apostolakou, Ioannis Papassotiriou, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Erasmia Psimenou, Asimina Papanikolaou, Charikleia Gakiopoulou, Smaragdi Marinaki, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Meletios‐Athanasios Dimopoulos, Efstathios Kastritis   +18 more
wiley   +1 more source

Serum cystatin C levels in Healthy Nigerian neonates: Is there a need for normative values in Nigerian babies?

Saudi Journal of Kidney Diseases and Transplantation, 2017
Cystatin C is an endogenous marker of renal function. Normal reference values have been documented in neonates outside Africa, but no study has been documented in African neonates. With reports that race may affect serum cystatin C values, this study was
Akpoembele D Madise-Wobo, Olusegun H Gbelee, Adaobi Solarin, Barakat A Animasahun, Olisamedua F Njokanma   +4 more
doaj   +1 more source

Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time

FEBS Open Bio, 2021
Some secreted cysteine protease inhibitors of the cystatin family appear to affect intracellular proteolysis and growth of human cells, as a result of internalization. Here, we studied the effects of external addition of the most abundant human cystatin,
Hanna Wallin, Samar Hunaiti, Magnus Abrahamson   +2 more
doaj   +1 more source

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes [PDF]

, 2011
This study was done to evaluate clinical usefulness of cystatin C levels of serum and urine in predicting renal impairment in normoalbuminuric patients with type 2 diabetes and to evaluate the association between albuminuria and serum/urine cystatin C ...
Bo Hyun Kim, Catalano, Choe, Comper, Gregg, Hong, In Joo Kim, Ji Young Mok, Jung Eun Huh, Keller, Knight, Kramer, Kramer, Lane, MacIsaac, Mi Ra Kim, Mussap, Myers, Oddoze, Olivarius Nde, Pucci, Rigalleau, Rigalleau, Sang Heon Song, Sang Soo Kim, Soo Hyoung Lee, Stevens, Stevens, Tsalamandris, Uslu, Wiesli, Wild, Yong Ki Kim, Yun Kyung Jeon   +33 more
core   +2 more sources

Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The aim of this study was to determine if head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin chemoradiotherapy and short hydration (SH) experience less dose‐limiting toxicity (DLT) and receive more cisplatin than those with medium hydration (MH) or long hydration (LH).
Anouk W. M. A. Schaeffers, Cassimy B. van Neerven, Dorieke van Balen, Mirjam Crul, Marije Slingerland, Saskia A. C. Luelmo, Jan Paul de Boer, Jens Voortman, Arjan D. van Zuilen, Remco de Bree, Lot A. Devriese   +10 more
wiley   +1 more source

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this phase 1 trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone (previously AZD9977) in participants with severe renal impairment vs. those with normal renal function. Methods Participants with severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2) not on dialysis were ...
Chandrali S. Bhattacharya, Hans Ericsson, Susanne Johansson, Joanna Parkinson, Simina M. Boca, Ye Yang, Maria Heijer, Greggory Housler, Maria Leonsson‐Zachrisson, Judith Hartleib‐Geschwindner, Patricia Ely Pizzato   +10 more
wiley   +1 more source